Next-generation treatment for severe systemic infections
We have a strong vision to develop effective and sustainable drugs based on original discoveries on body’s own anti-infective defenses. Today, there are no drugs that reduce severe inflammation and organ damage in patients with ARDS and septic shock. Moreover, in the approaching “post-antibiotic era”, antibiotics will have much decreased